Bacterin Announces Earnings Release and Conference Call Date for 2013 First Quarter Results

  Bacterin Announces Earnings Release and Conference Call Date for 2013 First
  Quarter Results

Business Wire

BELGRADE, Mont. -- April 30, 2013

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the
development of revolutionary bone graft material and coatings for medical
applications, today announced that it will release its financial results for
the period endedMarch 31, 2013, onMay 9, 2013 at the close of the financial

An accompanying conference call hosted by John Gandolfo, Chief Financial
Officer and interim Co-Chief Executive Officer, to discuss results will be
held at10:00 a.m. ET, onFriday, May 10, 2013. Please refer to the
information below for conference call dial-in information and webcast

Conference dial-in:      877-269-7756
International dial-in:     201-689-7817
Conference Call Name:      Bacterin’s First Quarter 2013 Results Call
Webcast Registration:      Click Here

Following the live call, a replay will be available on the Company's website,, under “Investor Info".

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures
and markets biologics products to domestic and international markets.
Bacterin's proprietary methods optimize the growth factors in human allografts
to create the ideal stem cell scaffold to promote bone, subchondral repair and
dermal growth. These products are used in a variety of applications including
enhancing fusion in spine surgery, relief of back pain, promotion of bone
growth in foot and ankle surgery, promotion of cranial healing following
neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses coatings
for various medical device applications. For further information, please visit

Important Cautions Regarding Forward-looking Statements

This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 that are subject to significant risks and
uncertainties. Forward-looking statements include statements that are
predictive in nature, that depend upon or refer to future events or
conditions, or that include words such as "continue," "efforts," "expects,"
"anticipates," "intends," "plans," "believes," "estimates," "projects,"
"forecasts," "strategy," "will," "goal," "target," "prospects," "potential,"
"optimistic," "confident," "likely," "probable" or similar expressions or the
negative thereof. Statements of historical fact also may be deemed to be
forward-looking statements. We caution that these statements by their nature
involve risks and uncertainties, and actual results may differ materially
depending on a variety of important factors, including, among others: the
Company's ability to launch beta and full product releases; the Company's
ability to meet its obligations under existing and anticipated contractual
obligations; the Company's ability to develop, market, sell and distribute
desirable applications, products and services and to protect its intellectual
property; the ability of the Company's sales force to achieve expected
results; the ability of the Company's customers to pay and the timeliness of
such payments, particularly during recessionary periods; the Company's ability
to obtain financing as and when needed; changes in consumer demands and
preferences; the Company's ability to attract and retain management and
employees with appropriate skills and expertise; the impact of changes in
market, legal and regulatory conditions and in the applicable business
environment, including actions of competitors; and other factors. Additional
risk factors are listed in the Company's Annual Report on Form 10-K under the
heading "Risk Factors." The Company undertakes no obligation to release
publicly any revisions to any forward-looking statements to reflect events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events, except as required by law.


For Bacterin International Holdings, Inc.
Rich Cockrell, 877-889-1972
Press spacebar to pause and continue. Press esc to stop.